Fulton Bank, N.A. Abbott Laboratories Transaction History

Fulton Bank, N.A.

$1.26 Billion
Q2 2025

A detailed history of Fulton Bank, N.A. transactions in Abbott Laboratories stock. As of the latest transaction made, Fulton Bank, N.A. holds 25,053 shares of ABT stock, worth $3.37 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

25,053

Previous 30,158 16.93%

Holding current value

$3.37 Million

Previous $4 Million 14.83%

% of portfolio

0.27%

Previous 0.35%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 10, 2025	SELL	$123.95 - $138.08 $632,764 - $704,898	-5,105 Reduced 16.93%	25,053 $3.41 Million
Q1 2025 Apr 09, 2025	BUY	$111.1 - $140.22 $44,106 - $55,667	397 Added 1.33%	30,158 $4 Million
Q4 2024 Jan 08, 2025	BUY	$111.93 - $119.39 $213,450 - $227,676	1,907 Added 6.85%	29,761 $3.37 Million
Q3 2024 Oct 07, 2024	SELL	$100.07 - $118.13 $4,903 - $5,788	-49 Reduced 0.18%	27,854 $3.18 Million
Q2 2024 Jul 09, 2024	BUY	$100.73 - $112.44 $198,538 - $221,619	1,971 Added 7.6%	27,903 $2.9 Million
Q1 2024 Apr 10, 2024	SELL	$109.52 - $120.96 $30,665 - $33,868	-280 Reduced 1.07%	25,932 $2.95 Million
Q4 2023 Jan 04, 2024	BUY	$90.19 - $110.4 $350,839 - $429,456	3,890 Added 17.43%	26,212 $2.89 Million
Q3 2023 Oct 04, 2023	BUY	$95.53 - $114.62 $83,397 - $100,063	873 Added 4.07%	22,322 $2.16 Million
Q2 2023 Jul 06, 2023	BUY	$100.78 - $112.29 $41,622 - $46,375	413 Added 1.96%	21,449 $2.34 Million
Q1 2023 Apr 06, 2023	SELL	$96.86 - $114.01 $55,694 - $65,555	-575 Reduced 2.66%	21,036 $2.13 Million
Q4 2022 Jan 05, 2023	BUY	$95.06 - $111.52 $13,403 - $15,724	141 Added 0.66%	21,611 $2.37 Million
Q3 2022 Oct 04, 2022	BUY	$96.76 - $112.03 $49,734 - $57,583	514 Added 2.45%	21,470 $2.08 Million
Q2 2022 Jul 07, 2022	BUY	$102.07 - $123.37 $29,498 - $35,653	289 Added 1.4%	20,956 $2.28 Million
Q1 2022 Apr 05, 2022	BUY	$114.02 - $139.04 $29,531 - $36,011	259 Added 1.27%	20,667 $2.45 Million
Q4 2021 Jan 05, 2022	BUY	$115.53 - $141.46 $114,028 - $139,621	987 Added 5.08%	20,408 $2.87 Million
Q3 2021 Oct 05, 2021	BUY	$116.66 - $129.06 $188,055 - $208,044	1,612 Added 9.05%	19,421 $2.29 Million
Q2 2021 Jul 06, 2021	BUY	$105.79 - $124.53 $33,323 - $39,226	315 Added 1.8%	17,809 $2.07 Million
Q1 2021 Apr 05, 2021	SELL	$108.84 - $128.23 $101,112 - $119,125	-929 Reduced 5.04%	17,494 $2.1 Million
Q4 2020 Jan 07, 2021	BUY	$105.0 - $114.42 $28,140 - $30,664	268 Added 1.48%	18,423 $2.02 Million
Q3 2020 Oct 06, 2020	SELL	$91.64 - $111.29 $472,220 - $573,477	-5,153 Reduced 22.11%	18,155 $1.98 Million
Q2 2020 Jul 06, 2020	BUY	$76.57 - $98.0 $34,073 - $43,610	445 Added 1.95%	23,308 $2.13 Million
Q1 2020 Apr 03, 2020	BUY	$62.82 - $91.86 $255,237 - $373,227	4,063 Added 21.61%	22,863 $1.8 Million
Q4 2019 Jan 24, 2020	BUY	$78.51 - $87.4 $45,928 - $51,129	585 Added 3.21%	18,800 $1.63 Million
Q3 2019 Oct 03, 2019	BUY	$81.84 - $88.74 $24,470 - $26,533	299 Added 1.67%	18,215 $1.52 Million
Q2 2019 Jul 03, 2019	SELL	$72.88 - $85.0 $3,716 - $4,335	-51 Reduced 0.28%	17,916 $1.51 Million
Q1 2019 Apr 03, 2019	SELL	$66.22 - $80.06 $99,462 - $120,250	-1,502 Reduced 7.71%	17,967 $1.44 Million
Q4 2018 Jan 03, 2019	BUY	$65.56 - $74.27 $6,162 - $6,981	94 Added 0.49%	19,469 $1.41 Million
Q3 2018 Oct 03, 2018	BUY	$60.81 - $73.36 $48,100 - $58,027	791 Added 4.26%	19,375 $1.42 Million
Q2 2018 Jul 10, 2018	SELL	$57.57 - $63.54 $15,946 - $17,600	-277 Reduced 1.47%	18,584 $1.13 Million
Q1 2018 May 02, 2018	SELL	$56.27 - $63.62 $86,374 - $97,656	-1,535 Reduced 7.53%	18,861 $1.13 Million
Q4 2017 Jan 04, 2018	SELL	$53.68 - $57.47 $260,025 - $278,384	-4,844 Reduced 19.19%	20,396 $1.16 Million
Q3 2017 Oct 04, 2017	BUY	$48.06 - $53.64 $1.21 Million - $1.35 Million	25,240	25,240 $1.35 Million

Others Institutions Holding ABT

# of Institutions

3,600

Shares Held

1.4B

Call Options Held

9.23M

Put Options Held

8.1M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Fulton Bank, N.A. with notifications on news.

Account